ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knight, J.
Right arrow Articles by Blaylock, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, J.
Right arrow Articles by Blaylock, R.
Annals of Clinical and Laboratory Science, Vol 22, Issue 6, 417-422
Copyright © 1992 by Association of Clinical Scientists


Articles

The effect of metal chelators on lipid peroxidation in irradiated erythrocytes

JA Knight, DA Searles, and RC Blaylock

Prophylactic irradiation of blood and blood components is accepted practice in order to prevent graft-versus-host disease from infused lymphocytes. Irradiation, however, results in increased red cell potassium (K+) loss, along with other possible effects that may affect red cell function and viability. Lipid peroxidation (LP), a process initiated by the production of oxygen free radicals, is increased in red cells in the presence of reactive iron species and various heme moieties. In this report, it is noted that not only is plasma K+ significantly increased following blood irradiation, but LP is also increased compared with paired non-irradiated blood samples. Furthermore, various metal chelators significantly reduce LP in the irradiated samples. These chelators also significantly reduced the rate of cellular K+ loss during the four day 37 degrees C incubation period. This study further suggests that the addition of selected metal chelators may be effective in both irradiated and non-irradiated stored blood by improving the function and viability of transfused erythrocytes.


This article has been cited by other articles:


Home page
BloodHome page
J. Turner, C. Koumenis, T. E. Kute, R. P. Planalp, M. W. Brechbiel, D. Beardsley, B. Cody, K. D. Brown, F. M. Torti, and S. V. Torti
Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation
Blood, November 1, 2005; 106(9): 3191 - 3199.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Samuni, D. Coffin, A. M. DeLuca, W. G. DeGraff, D. J. Venson, I. Ambudkar, M. Chevion, and J. B. Mitchell
The Use of Zn-Desferrioxamine for Radioprotection in Mice, Tissue Culture, and Isolated DNA
Cancer Res., January 1, 1999; 59(2): 405 - 409.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the Association of Clinical Scientists.